Items tagged with Diagnostics
New digital technologies for TB detection added to the GDF catalog (post)
The Stop TB Partnership’s Global Drug Facility (GDF) announced the inclusion in its catalog, for the first time ever, of two ultra-portable digital X-ray systems and two software packages for the computer-aided detection of TB based on artificial intelligence. These important digital tools to combat TB will be made available at a reduced cost to all TB programs in low- and middle-income countries.
Deep learning triages chest X-rays with TB, rivaling radiologists and pulmonary experts (post)
A new deep learning model rivaled radiologists’ accuracy at assessing tuberculosis on chest X-rays. The tool may prove particularly useful for triaging patients in low-resource settings.
Target product profile for next-generation TB drug-susceptibility testing at peripheral sites (post)
10 August 2021 | Geneva - The World Health Organization (WHO) is launching its updated target product profile (TPP) for next-generation drug-susceptibility (DST) testing for M. tuberculosis at peripheral centres.
Public call for data on diagnostic accuracy of newer skin-based tests based on specific M. tuberculosis antigens (post)
12 August 2021, Geneva | Currently the most widely used diagnostic tests for TB infection are the tuberculin skin test (TST) and interferon gamma release assays (IGRA). However, both classes of tests have limitations. Newer skin-based tests based on specific M. tuberculosis antigens (ESAT-6, CFP-10 and others) have been developed, these combine the simpler skin-test platform with the specificity of IGRA. Emerging evidence suggests that compared to IGRA, the tests may have similar specificity and provide more reliable results in children and in HIV-infected cohorts. However, the evidence has not been systematically reviewed.
WHO issues rapid communication on updated guidance for the management of TB in children and adolescents (post)
26 August 2021 | Geneva - A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme has announced important updates to guidance on the management of tuberculosis (TB) in children and adolescents. This includes new recommendations on diagnostic options, treatment regimens, as well as treatment decision algorithms and optimal models of care for the delivery of child and adolescent TB services.
The results are in: Artificial intelligence outperforms humans at reading chest x-rays for signs of TB (post)
24 August 2021, Geneva, Switzerland – Lancet Digital Health just published the new ground-breaking study by the Stop TB Partnership, showing that artificial intelligence (AI) by far outperformed experienced human radiologists in diagnosing tuberculosis (TB).
How our skin smells could be a sign of TB (post)
Researchers are devising a quicker and cheaper way to diagnose tuberculosis — and it’s based on how your skin smells.
WHO sets up an Advisory Group on TB Diagnostics and Laboratory Strengthening (post)
27 September 2021 | Geneva: The World Health Organization (WHO) has established a new technical advisory group that will advise on TB diagnostic tools and strategies, and complement the WHO guideline development process.
The Lancet Commission on diagnostics: transforming access to diagnostics (post)
Executive summary
QIAGEN launches novel QIAreach QuantiFERON-TB tuberculosis test for high-burden regions (post)
--QIAGEN leverages QuantiFERON®-TB technology to advance global efforts against TB
--TB IGRA testing now accessible in high burden, low resource and decentralized settings
--Study data also showcased at the Union World Conference show promising results
Page 42 of 70 · Total posts: 0
←First 41 42 43 Last→